Chronic Normocytic Anemia
Learn about Chronic Normocytic Anemia, also known as Anemia of Chronic Disease, including clinical documentation tips for healthcare professionals. This resource covers key aspects of normocytic anemia diagnosis, medical coding considerations, and relevant information for accurate healthcare records. Understand the connection between chronic disease and anemia for improved patient care and documentation.
Anemia with normal-sized red blood cells often linked to underlying chronic inflammation or disease.
Fatigue, weakness, shortness of breath, pale skin, headaches, dizziness.
Chronic kidney disease, inflammatory disorders, infections, cancer.
ICD-10 Code Families
Complete code families applicable to D64.9
When to use each related code
| Description | When to use |
|---|---|
| Anemia with normal-sized red blood cells, often tied to chronic inflammation. | Code when anemia is associated with chronic conditions like infections, inflammation, or cancer. |
| Iron deficiency resulting in small, pale red blood cells. | Code when microcytic, hypochromic anemia is present with low ferritin and/or transferrin saturation. Consider iron studies. |
| Anemia due to vitamin B12 or folate deficiency, causing large red blood cells. | Code when macrocytic anemia is present and serum B12 or folate levels are low. Check for neurological symptoms. |
Best-practice checklist
- ✓Document underlying chronic disease (e.g., RA, CKD)
- ✓Hgb/Hct below normal limits
- ✓MCV within normal range (80-100 fL)
- ✓Assess iron studies (ferritin, TIBC)
- ✓Exclude other anemia causes (B12, folate)
Common pitfalls to avoid
Coding as unspecified anemia (D64.9) without proper documentation of chronic disease link, leading to lower reimbursement and potential denials.
Insufficient documentation linking normocytic anemia to chronic inflammation, infection or malignancy impacting accurate code assignment (e.g., D63.8).
Miscoding as iron deficiency anemia (D50.9) due to similar lab findings, requiring careful review of iron studies and underlying condition.
Best-practice tips
- 01Document underlying chronic disease (ICD-10 coding)
- 02Evaluate iron studies, CRP, ESR for ACD diagnosis (CDI)
- 03Consider EPO if CKD-related, follow KDIGO guidelines
- 04Exclude other anemia causes (Iron, B12, Folate) for compliance
- 05Transfuse PRBCs judiciously, monitor Hb trends (patient safety)
Step-by-step checklist
- 1
1. Confirm normocytic anemia: Check MCV (80-100 fL). Document in EHR.
- 2
2. Evaluate for underlying chronic disease: Inflammation, infection, malignancy.
- 3
3. Rule out other anemia causes: Iron, B12, folate deficiency. Review labs.
- 4
4. Assess iron studies: Ferritin, transferrin saturation. Check for functional iron deficiency.
- 5
5. Consider bone marrow biopsy if diagnosis unclear. Document rationale.
Ready-to-paste narrative
Patient presents with signs and symptoms suggestive of chronic normocytic anemia, also known as anemia of chronic disease. The patient reports fatigue, weakness, and decreased exercise tolerance. Physical examination may reveal pallor, but no other significant findings are noted. Laboratory evaluation demonstrates a normocytic, normochromic anemia with a hemoglobin level below the reference range. Mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) are within normal limits. Further workup includes serum iron, ferritin, total iron-binding capacity (TIBC), transferrin saturation, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) to differentiate from iron deficiency anemia and other causes of anemia. The patient's underlying chronic condition, documented as [Insert specific underlying chronic disease, e.g., rheumatoid arthritis, chronic kidney disease, inflammatory bowel disease], is considered the primary etiology of the anemia. Differential diagnosis includes iron deficiency anemia, thalassemia, and sideroblastic anemia. Diagnosis of chronic normocytic anemia is established based on the clinical presentation, laboratory findings, and the presence of a chronic inflammatory condition. Treatment will focus on managing the underlying chronic disease. Iron supplementation is generally not indicated unless concomitant iron deficiency is confirmed. Patient education regarding the relationship between the underlying disease and the anemia has been provided. Follow-up laboratory testing will be scheduled to monitor hemoglobin levels and assess response to treatment of the underlying condition. ICD-10 code [Insert appropriate ICD-10 code, e.g., D63.0, D63.8] is applied.
Common questions and answers
How to differentiate between Chronic Normocytic Anemia and Iron Deficiency Anemia in a patient with chronic inflammation?+
Differentiating between Chronic Normocytic Anemia (ACD) and Iron Deficiency Anemia (IDA) in patients with chronic inflammation can be challenging due to overlapping symptoms. While both can present with fatigue and reduced exercise tolerance, key distinguishing factors include the mean corpuscular volume (MCV), which is typically normal (80-100 fL) in ACD and low (<80 fL) in IDA. Serum ferritin levels can be misleading in inflammation; however, a low serum iron, high transferrin saturation, and low transferrin receptor-ferritin index often point toward IDA. In contrast, ACD typically presents with normal or slightly elevated ferritin, low serum iron, low transferrin saturation, and a normal or slightly elevated transferrin receptor-ferritin index. Soluble transferrin receptor (sTfR) can be helpful, as it is elevated in IDA but normal or only slightly elevated in ACD. Bone marrow examination is rarely necessary but can confirm iron deficiency. Consider implementing a thorough iron panel alongside inflammatory marker assessment to guide your diagnosis. Explore how incorporating these tests into your diagnostic workup can improve the accuracy of differentiating between ACD and IDA. Learn more about the role of cytokines like hepcidin in the pathogenesis of ACD.
What is the best management approach for Chronic Normocytic Anemia associated with rheumatoid arthritis?+
Managing Chronic Normocytic Anemia (ACD) in rheumatoid arthritis patients requires a multifaceted approach. Addressing the underlying inflammatory condition is paramount. Disease-modifying antirheumatic drugs (DMARDs), including methotrexate, sulfasalazine, and biologic agents like TNF inhibitors, can help control the inflammation driving ACD. While iron supplementation may seem intuitive, it is generally ineffective and potentially harmful in ACD unless true iron deficiency coexists. Erythropoiesis-stimulating agents (ESAs) like epoetin alfa or darbepoetin alfa can be considered in select cases where the anemia significantly impacts quality of life and other causes of anemia have been excluded. However, ESAs should be used cautiously, considering potential risks like thrombosis and hypertension. Regular monitoring of hemoglobin, iron studies, and inflammatory markers is crucial. Consider implementing a collaborative care strategy involving rheumatology and hematology to optimize management for your patients. Learn more about the latest guidelines for ESA use in ACD.
When should I suspect Chronic Normocytic Anemia and what initial investigations should I order?+
Suspect Chronic Normocytic Anemia (often termed Anemia of Chronic Disease) in patients with chronic inflammatory conditions such as infections (e.g., tuberculosis, osteomyelitis), autoimmune diseases (e.g., rheumatoid arthritis, lupus), or malignancies, and who present with normochromic, normocytic anemia. Initial investigations should include a complete blood count (CBC) to confirm anemia and assess MCV, a comprehensive metabolic panel (CMP) to evaluate renal function and other metabolic abnormalities, inflammatory markers (e.g., C-reactive protein, erythrocyte sedimentation rate), and iron studies including serum iron, ferritin, transferrin saturation, and total iron binding capacity (TIBC). Further investigations like soluble transferrin receptor (sTfR) and reticulocyte count can aid in distinguishing ACD from other anemias. Consider implementing a stepwise approach to testing, starting with basic investigations and escalating based on initial findings and clinical suspicion. Explore how specific patterns in these tests can pinpoint the underlying cause and guide appropriate management strategies.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.